A carregar...

Model-based clinical pharmacology profiling of ipilimumab in patients with advanced melanoma

AIM: Ipilimumab is a fully human, monoclonal antibody that blocks cytotoxic T-lymphocyte antigen-4. The objective of the present study was to characterize the clinical pharmacology profile of ipilimumab using a population pharmacokinetic (PPK) approach. METHODS: The PPK model was developed using 209...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Feng, Yan, Masson, Eric, Dai, David, Parker, Susan M, Berman, David, Roy, Amit
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Science Inc 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4168385/
https://ncbi.nlm.nih.gov/pubmed/24433434
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12323
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!